Medexus Pharmaceuticals (MDP) Stock Chart & Stock Price History C$2.43 +0.05 (+2.10%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Medexus Pharmaceuticals Stock Price Performance5 Day Performance-5.45%1 Month Performance-5.45%3 Month Performance+6.58%6 Month Performance+37.29%Year-To-Date Performance-1.62%1 Year Performance+19.70% Receive MDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. MDP Stock Chart for Saturday, November, 2, 2024 MDP Chart by TradingView Medexus Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024C$2.38C$2.43+2.10%C$2.44C$2.389,972 shsC$59.61 million10/31/2024C$2.55C$2.38-6.67%C$2.56C$2.2927,920 shsC$58.38 million10/30/2024C$2.58C$2.55-1.16%C$2.59C$2.555,840 shsC$62.55 million10/29/2024C$2.57C$2.58+0.39%C$2.62C$2.555,800 shsC$63.29 million10/28/2024C$2.56C$2.57+0.39%C$2.57C$2.486,448 shsC$63.04 million10/25/2024C$2.59C$2.56-1.16%C$2.59C$2.5310,500 shsC$62.80 million Get the Latest News and Ratings for MDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024C$2.50C$2.59+3.60%C$2.59C$2.506,900 shsC$63.53 million10/23/2024C$2.46C$2.50+1.63%C$2.51C$2.4733,700 shsC$61.33 million10/22/2024C$2.50C$2.46-1.60%C$2.53C$2.468,900 shsC$60.34 million10/21/2024C$2.52C$2.50-0.79%C$2.52C$2.4516,900 shsC$61.33 million10/18/2024C$2.60C$2.52-3.08%C$2.62C$2.5213,000 shsC$61.82 million10/17/2024C$2.57C$2.60+1.17%C$2.62C$2.574,301 shsC$63.78 million10/16/2024C$2.59C$2.57-0.77%C$2.61C$2.574,100 shsC$63.04 million10/15/2024C$2.60C$2.59-0.38%C$2.67C$2.5023,810 shsC$63.53 million10/14/2024C$2.60C$2.60C$2.67C$2.5914,738 shsC$63.78 million10/11/2024C$2.67C$2.60-2.62%C$2.67C$2.5914,740 shsC$63.78 million10/10/2024C$2.65C$2.67+0.75%C$2.67C$2.644,504 shsC$65.50 million10/09/2024C$2.68C$2.65-1.12%C$2.70C$2.6310,200 shsC$65.00 million10/08/2024C$2.67C$2.68+0.37%C$2.70C$2.6311,350 shsC$65.74 million10/07/2024C$2.68C$2.67-0.37%C$2.68C$2.5728,460 shsC$65.50 million10/04/2024C$2.64C$2.68+1.52%C$2.68C$2.669,000 shsC$65.74 million10/03/2024C$2.57C$2.64+2.72%C$2.65C$2.596,700 shsC$64.76 million10/02/2024C$2.58C$2.57-0.39%C$2.62C$2.526,149 shsC$63.04 million10/01/2024C$2.65C$2.58-2.64%C$2.61C$2.4068,816 shsC$63.29 million09/30/2024C$2.67C$2.65-0.75%C$2.67C$2.6325,401 shsC$65.00 million09/27/2024C$2.58C$2.67+3.49%C$2.69C$2.597,903 shsC$65.50 million09/26/2024C$2.59C$2.58-0.39%C$2.62C$2.5414,501 shsC$63.29 million09/25/2024C$2.60C$2.59-0.38%C$2.61C$2.5117,300 shsC$63.53 million09/24/2024C$2.60C$2.60C$2.63C$2.4919,750 shsC$63.78 million09/23/2024C$2.55C$2.60+1.96%C$2.60C$2.5051,000 shsC$63.78 million09/20/2024C$2.50C$2.55+2.00%C$2.55C$2.5121,000 shsC$62.55 million09/19/2024C$2.46C$2.50+1.63%C$2.52C$2.4519,231 shsC$61.33 million09/18/2024C$2.42C$2.46+1.65%C$2.48C$2.3917,550 shsC$60.34 million09/17/2024C$2.33C$2.42+3.86%C$2.47C$2.3334,601 shsC$59.36 million09/16/2024C$2.73C$2.33-14.65%C$2.49C$2.12136,020 shsC$57.16 million09/13/2024C$2.72C$2.73+0.37%C$2.73C$2.6831,415 shsC$66.97 million09/12/2024C$2.68C$2.72+1.49%C$2.74C$2.6826,931 shsC$66.72 million09/11/2024C$2.65C$2.68+1.13%C$2.68C$2.6211,300 shsC$65.74 million09/10/2024C$2.68C$2.65-1.12%C$2.72C$2.6520,845 shsC$65.00 million09/09/2024C$2.68C$2.68C$2.68C$2.647,697 shsC$65.74 millionCrypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now.09/06/2024C$2.70C$2.68-0.74%C$2.72C$2.6514,720 shsC$65.74 million09/05/2024C$2.58C$2.70+4.65%C$2.75C$2.6244,766 shsC$66.23 million09/04/2024C$2.42C$2.58+6.61%C$2.58C$2.4316,502 shsC$63.29 million09/03/2024C$2.45C$2.42-1.22%C$2.46C$2.4013,700 shsC$59.36 million09/02/2024C$2.45C$2.45C$2.45C$2.415,650 shsC$60.10 million08/30/2024C$2.42C$2.45+1.24%C$2.45C$2.415,650 shsC$60.10 million08/29/2024C$2.50C$2.42-3.20%C$2.49C$2.4014,820 shsC$59.36 million08/28/2024C$2.43C$2.50+2.88%C$2.50C$2.4325,331 shsC$61.33 million08/27/2024C$2.46C$2.43-1.22%C$2.45C$2.4020,725 shsC$59.61 million08/26/2024C$2.43C$2.46+1.23%C$2.47C$2.435,700 shsC$60.34 million08/23/2024C$2.41C$2.43+0.83%C$2.46C$2.3922,355 shsC$59.61 million08/22/2024C$2.40C$2.41+0.42%C$2.41C$2.3842,620 shsC$59.12 million08/21/2024C$2.41C$2.40-0.41%C$2.41C$2.4013,400 shsC$58.87 million08/20/2024C$2.46C$2.41-2.03%C$2.46C$2.4015,750 shsC$59.12 million08/19/2024C$2.35C$2.46+4.68%C$2.50C$2.4012,515 shsC$60.34 million08/16/2024C$2.43C$2.35-3.29%C$2.44C$2.2821,336 shsC$57.65 million08/15/2024C$2.49C$2.43-2.41%C$2.50C$2.438,010 shsC$59.61 million08/14/2024C$2.49C$2.49C$2.70C$2.4368,301 shsC$60.91 million08/13/2024C$2.38C$2.49+4.62%C$2.55C$2.3854,078 shsC$60.91 million08/12/2024C$2.39C$2.38-0.42%C$2.40C$2.3411,340 shsC$58.22 million08/09/2024C$2.46C$2.39-2.85%C$2.46C$2.3915,669 shsC$58.46 million08/08/2024C$2.27C$2.46+8.37%C$2.47C$2.2965,027 shsC$60.17 million08/07/2024C$2.23C$2.27+1.79%C$2.30C$2.2517,709 shsC$55.52 million08/06/2024C$2.28C$2.23-2.19%C$2.27C$2.1515,605 shsC$54.55 million08/05/2024C$2.28C$2.28C$2.35C$2.1545,640 shsC$55.77 million08/02/2024C$2.35C$2.28-2.98%C$2.35C$2.1545,640 shsC$55.77 million08/01/2024C$2.41C$2.35-2.49%C$2.45C$2.3515,400 shsC$57.48 million Related Companies Cardiol Therapeutics Stock Chart BioSyent Stock Chart HLS Therapeutics Stock Chart SugarBud Craft Growers Stock Chart Charlotte's Web Stock Chart MediPharm Labs Stock Chart Decibel Cannabis Stock Chart Willow Biosciences Stock Chart Crescita Therapeutics Stock Chart Voyageur Pharmaceuticals Stock Chart Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:MDP) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
